Pfizer Inc and BioNTech SE submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as children ages 5 through <12).
- Read more about Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/pfizer-and-biontech-submit-application-for-us-emergency-use-authorization-for-a-covid-19-vaccine-booster-dose-in-children-5-through-11-years-of-age
No comments:
Post a Comment